Pharma Manufacturing

With demand increasing, driven by biologics, biosimilars, and high-potency therapies, the Young Institute Pharmaceutical Manufacturing Consortium,?a partnership?between Purdue University, Eli Lilly, and Merck, is focused on advancing AI-driven automation, robotics, and novel aseptic processing methods to improve efficiency, quality, and safety in injectable drug manufacturing. Read the full article here https://lnkd.in/gz8EpSFH Eli Lilly and Company #EliLilly #Merck #PerdueUniversity #automation #AIautomation #robotics #pharmamanufacturing #sterileinjectables

Biopharma company Viking Therapeutics, Inc.?announced?a multi-year, $150 million manufacturing agreement with CordenPharma for the active pharmaceutical ingredient (API) and final finished product supply for Viking’s VK2735 obesity drug candidate. Read more https://lnkd.in/ghmcnezV #VikingTherapeutics #biopharma #manufacturingagreement #CordenPharma #API #obesitydrug #pharmanews #pharmamanufacturing

The Noramco Group is?investing?$25 million in its Halo Pharma facility in Whippany, New Jersey, to bolster sterile injectable manufacturing capabilities at the site. Read more here https://lnkd.in/gWgCKRUT #NoramcoGroup #Noramco #HaloPharma #sterileinjectable #pharmamanufacturing #pharmanews

India-based contract research, development, and manufacturing organization (CRDMO) Syngene International?announced?it is paying $36.5 million to Emergent Manufacturing Operations Baltimore, a subsidiary of Emergent BioSolutions, to acquire its first biologics site in the U.S. Read more https://lnkd.in/dtv7GuUC Syngene International Limited #SyngeneInternational #EmergentBiosolutions #CRDMO #CDMO #acquisition #pharmanews #pharmamanufacturing

Amaran Biotechnology, a Taiwan-based contract development and manufacturing organization (CDMO) and subsidiary of OBI Pharma, has?signed?a memorandum of understanding with Japan’s Nippon Fine Chemical and its Taiwan subsidiary, Zillion Fine Chemicals International. Read more https://lnkd.in/g8R9us-G #AmaranBiotechnology #CDMO #OBIPharma #NipponFineChemical #ZillionFineChemicalsInternational #pharmanews #pharmamanufacturing

While Eli Lilly is spending tens of billions of dollars to meet the increasing demand for its wildly popular diabetes and obesity drugs, it will take years for the drugmaker to see volume expansion for its blockbuster medications Mounjaro and Zepbound, CFO Lucas Montarce?told?the Leerink Partners Global Healthcare Conference on Monday. Read more here https://lnkd.in/gDqn7PkU Eli Lilly and Company #EliLilly #obesitydrug #diabetesdrug #Mounjaro #Zepbound #LeerinkPartnersGlobalHealthcareConference #pharmanews #pharmamanufacturing

Europe’s dependency on critical medicines is a vulnerability that could “severely undermine” its security and defense capabilities, according to an?op-ed?from the health ministers of 11 European Union member states. Read more https://lnkd.in/dct3B2rd #EU #pharmanews #pharmamanufacturing #criticalmedicines

As an India-based contract research, development, and manufacturing organization (CRDMO), Aragen Life Sciences stands to benefit as the biopharma industry looks to derisk its supply chains and shift outsourcing away from China to Indian service providers. Read more here https://lnkd.in/dC-Q6TKj #Aragenlifesciences #pharmanews #pharmamanufacturing #CRDMO #supplychain #biopharmaindustry

Enzene has?received?European Union (EU) Good Manufacturing Practice (GMP) certification for its two facilities in Pune, India, allowing the company to supply microbial and mammalian drug substances?—?as well as drug product fill-finish and packaging?—?for commercial use in the EU markets. Read more here https://lnkd.in/eDTQMpN7 #GMPcertification #Enzene #EU #EuropeanUnion #pharmanews #pharmamanufacturing

Lonza’s Capsules & Health Ingredients (CHI) business has?announced?the launch of a new Center of Applied Sustainability to help its customers reduce their emissions, aiming to achieve the lowest possible environmental impacts for the CHI product portfolio. Read more https://lnkd.in/e7TH3AHr #Lonza #LonzaCHI #sustainability #emissions #environmentalimpacts #manufacturingsustainability #pharmanews #pharmamanufacturing